<scp>TGF</scp> ‐β1 peptide‐based inhibitor <scp>P144</scp> ameliorates renal fibrosis after ischemia–reperfusion injury by modulating alternatively activated macrophages-Reference-Cited by-同舟云学术

TGF ‐β1 peptide‐based inhibitor P144 ameliorates renal fibrosis after ischemia–reperfusion injury by modulating alternatively activated macrophages

Published:2022-06-28 Issue:10 Volume:55 Page:
ISSN:0960-7722
Container-title:Cell Proliferation
language:en
Short-container-title:Cell Proliferation

Author:

Li Delun¹²,Zhang Jian¹,Yuan Siyu¹,Wang Chao¹³,Chang Jiakai¹,Tong Yan¹,Liu Ran¹,Sang Tian¹,Li Lili⁴,Li Jijun¹,Ouyang Qing¹^ORCID,Chen Xiangmei¹²

Affiliation:

1. Department of Nephrology, First Medical Center of Chinese PLA General Hospital, Nephrology Institute of the Chinese People's Liberation Army, State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases Beijing Key Laboratory of Kidney Disease Research Beijing China

2. School of Clinical Medicine Guangdong Pharmaceutical University Guangzhou China

3. School of Traditional Chinese Medicine Guangdong Pharmaceutical University Guangzhou China

4. CAS Center for Excellence in Nanoscience, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety National Center for Nanoscience and Technology (NCNST) Beijing China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cell Biology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cpr.13299

Reference29 articles.

1. Diverse Role of TGF-β in Kidney Disease

2. Bone Marrow–Derived Myofibroblasts Contribute to the Renal Interstitial Myofibroblast Population and Produce Procollagen I after Ischemia/Reperfusion in Rats

3. Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. (+)‐Catechins Play a Protective Role in Diabetic Kidney Disease by Alleviating EMT through Multiple Pathways;Molecular Nutrition & Food Research;2024-08-09

2. Emodin inhibits M1 macrophage activation that related to acute and chronic kidney injury through EGFR/MAPK pathway;Functional & Integrative Genomics;2024-07-30

3. Depleting profibrotic macrophages using bioactivated in vivo assembly peptides ameliorates kidney fibrosis;Cellular & Molecular Immunology;2024-06-13

4. Corneal fibrosis: From in vitro models to current and upcoming drug and gene medicines;Advanced Drug Delivery Reviews;2024-06

5. Targeting Macrophages: Therapeutic Approaches in Diabetic Kidney Disease;International Journal of Molecular Sciences;2024-04-15